MAYOLY SPINDLER Committed to your health. Every day - 18-INS-073
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
MAYOLY SPINDLER
Committed to your health.
Every day.
18-INS-073
OUR AMBITION
Become an
international reference
in gastroenterology
and dermo-cosmetics
2
CONTENTS
OUR ASSETS OUR FIELDS OF OUR EMPLOYEES’
A French company EXPERTISE COMMITMENT
An independent company Pharmaceuticals Our values
An extensive global footprint Dermo-cosmetics A responsible company
Contract Development &
Manufacturing
3
CORPORATE PRESENTATION 24/08/2018
OUR ASSETS
a French company
▪ Three manufacturing facilities near Paris, 1 in Chatou
(West of Paris) and 2 in Dammarie-les-Lys (East of Paris).
▪ Over 880 employees worldwide, including nearly 610 in
France.
▪ Turnover: €190 million in 2017.
▪ 70% of products sold are made in France.
▪ An economic player contributing to France’s status as one
of the world’s leading pharmaceuticals exporters*.
* Source: LEEM (French Pharmaceutical Companies Association)– Economic report, 2016 issue.
4
CORPORATE PRESENTATION 24/08/2018
OUR ASSETS NET CONSOLIDATED TURNOVER
an independent company 2009-2017 (€ million)
200 190
▪ Founded in 1909: for more than a century, an 180
154 159 161
167 173
entrepreneurial adventure.
160 145
138
140 126
▪ Still an entirely family-owned company.
120
100
▪ Financial independence, a main performance driver.
80
60
▪ Uninterrupted growth laying the foundations for the 40
20
company’s long-term development. 0
2009 2010 2011 2012 2013 2014 2015 2016 2017
5
CORPORATE PRESENTATION 24/08/2018
OUR ASSETS
an extensive global footprint
▪ Established worldwide in more than 70 countries generating
45% of overall turnover (vs France 55%)
▪ Dynamic subsidiaries: in Europe, Eastern Europe, Asia and
Latin America (32% of international turnover in 2017)
▪ Business partners committed for the long term
▪ A proactive development policy
▪ With the acquisition in 2016 of Kibion, a Swedish company
principally operating in Germany and the Middle East,
Subsidiaries
Mayoly Spindler has become one of the world leaders in the
detection and control of Helicobacter pylori infections. Distributors
6
CORPORATE PRESENTATION 24/08/2018
OUR FIELDS OF
EXPERTISE
7
PHARMACEUTICALS
8
PHARMACEUTICALS BREAKDOWN OF TURNOVER
Our historical pillar of development BY BUSINESS SECTOR IN 2017
CDMO *
Dermo-cosmetics €13 million
€23 million
7%
▪ Pharmaceutical sector: 80% of overall turnover in 2016
13 %
▪ Gastroenterology: 70% of our pharmaceutical business.
▪ A portfolio of therapeutic solutions spanning speciality
care, primary care and self-medication.
80 %
▪ An investment in collaborative R&D in gastroenterology.
Pharmaceuticals
€154 million
* Contract Development & Manufacturing Organization
9
CORPORATE PRESENTATION 24/08/2018
OUR THERAPEUTIC SOLUTIONS PORTFOLIO
Biliary lithiasis Acid reflux
Biliary cirrhosis
Travel sickness Gaz
Diagnostics tests
Digestive and renal
Abdominal pains elimination functions
Crohn’s disease Heartburn
Probiotics/Gut flora
Pancreatic insufficiency
Cystic fibrosis
Colonoscopy Constipation
10
CORPORATE PRESENTATION 24/08/2018DERMO-COSMETICS
11DERMOCOSMETICS BREAKDOWN OF TURNOVER
Topicrem, the science of hydration BY BUSINESS SECTOR IN 2017
▪ Ultra-Moisturizing Body Milk
is the n°1 body moisturizer in France*. Dermo cosmetics
€23 million CDMO *
▪ High-quality manufacturing standards recognized on an €13 million
international level.
7%
▪ All worldwide production of Topicrem is made in France 13 %
(Dammarie-Les-Lys).
▪ An international brand (50% of Topicrem sales generated
outside of France). 80 %
Pharmaceuticals
* France IMS data Décembre 2016.
€154 million
* Contract Development & Manufacturing Organization
12
CORPORATE PRESENTATION 24/08/2018PRODUCTION &
CONTRACT
MANUFACTURING
13PRODUCTION & CONTRACT
MANUFACTURING BREAKDOWN OF TURNOVER
BY BUSINESS SECTOR IN 2017
Technical prowess and responsiveness
CDMO *
▪ An agile structure offering our customers a wide range of €13 million
possibilities that meet their requirements in pharmaceuticals, Dermo cosmetics
nutraceuticals and dermo-cosmetics €23 million 7%
▪ A diversified offer: softgel capsules, tablets, capsules,
syrups, creams… 13 %
▪ A softgel capsules expertise requiring a particular
technicality. 80 %
▪ They trust us:
Pharmaceuticals
€154 million
* Contract Development & Manufacturing Organization
14
CORPORATE PRESENTATION 24/08/2018OUR EMPLOYEES’
COMMITMENT,
CENTRAL TO OUR
SUCCESS
15OUR VALUES
RESPONSIBILITY RESPECT PRAGMATISM
Our performance is the result of the talent of our employees who, every day, share ambitious projects
and a test for challenge.
Our corporate culture is reflected in the empowerment of our teams, the opportunity to take initiatives
and the pragmatism of each individual.
Mayoly Spindler is a company where respect goes hand-in-hand with growth,
fostering the well-being of everyone.
16
CORPORATE PRESENTATION 24/08/2018A RESPONSIBLE COMPANY
▪ OUR MAYOLY, our corporate responsibility programme.
▪ Three priorities: workplace well-being, commitment to the
community and care for the environment.
▪ Projects designed and coordinated by employees,
working in the general interest.
PRESENTATION EXCLUSIVELY 17
24/08/2018
FOR OFFICIAL BODIESMAYOLY
SPINDLER
AT A GLANCE
18€190 million turnover 45%
of turnover generated
Pharmaceuticals: 80%
outside of France.
Dermo-cosmetics: 13%
Production: 7%
Over 880 3 production sites
employees worldwide, near Paris: 1 in Chatou
including 610 in France. and 2 in Dammarie-les-lys
19
Figures as at 31/12/2017.Committed to your health.
Every day.You can also read
